This is a non-core endpoint: only basic statistics are computed.
Carcinoma in situ of skin of eyelid, including canthus
CD2_INSITU_SKIN_EYELID
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
77 |
4. Check minimum number of eventsNone |
77 |
5. Include endpointsNone |
77 |
6. Filter based on genotype QC (FinnGen only) |
74 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D04
- Name in latin
- Carcinoma in situ cutis palpebrae
Carcinoma in situ of skin of eyelid, including canthus
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 74 | 33 | 41 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | 77.58 | 77.03 | 78.03 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 77
- Matched controls
- 770
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D04.1
ICD-10 Finland
Carcinoma in situ: Skin of eyelid, including canthus
+∞
107.9
76
*
L57.0
ICD-10 Finland
Actinic keratosis
9.6
22.8
43
90
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
28.9
20.0
27
14
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
9.0
17.8
28
46
TQW99
NOMESCO Finland
Other minor procedure on skin
12.9
13.2
24
26
CBA10
NOMESCO Finland
Biopsy of eyelid
36.6
12.2
15
5
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
140.1
11.8
12
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
26.1
11.2
15
7
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.3
10.3
27
71
CBB30
NOMESCO Finland
Excision of lesion of eyelid
18.2
10.0
15
10
R23.8
ICD-10 Finland
Other and unspecified skin changes
4.6
9.4
31
98
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
11.3
8.2
15
16
ZXC15
NOMESCO Finland
Use of photodynamic technique
15.5
7.7
12
9
S21
ICPC
Skin texture symptom/complaint
4.5
7.6
23
67
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
4.6
7.5
22
62
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
5.2
7.2
17
40
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
10.2
6.9
13
15
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
10.7
6.6
12
13
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
4.9
6.5
16
39
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
+∞
6.3
6
*
C44.12
ICD-10 Finland
Spinocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
35
121
4.47
9.43
2.4
1.7
—
—
—
0
0
18
38
5.88
8.62
2.2
1.4
—
—
—
0
0
23
80
3.67
5.81
1.9
1.6
—
—
—
0
0
23
82
3.57
5.58
1.9
1.6
—
—
—
0
0
15
48
3.64
4.19
1.5
1.5
—
—
—
0
0
45
277
2.50
3.75
2.6
2.1
89.01
89.52
pmol/l
0.03
27
132
28
140
2.57
3.61
3.5
2.1
—
—
—
0
0
43
266
2.40
3.46
2.4
2.3
—
—
—
0
0
11
28
4.40
3.45
3.3
1.9
—
—
—
0
0
69
554
3.36
3.40
30.2
18.2
33.69
24.26
mg/l
0.96
59
467
61
445
2.78
3.39
5.0
4.5
19.60
14.89
mm/h
0.87
55
403
23
108
2.61
3.33
4.1
2.9
0.83
1.09
e6/l
0.30
16
66
31
170
2.38
3.23
2.5
2.1
3.06
3.21
mg/l
0.11
26
149
41
258
2.26
3.06
3.5
2.4
—
—
—
0
0
5
5
10.56
3.02
1.2
1.4
—
—
—
0
0
8
17
5.12
3.01
1.4
1.2
—
—
—
0
0
8
17
5.12
3.01
1.4
1.2
—
—
—
0
0
70
578
3.32
2.97
33.3
21.5
98.66
86.84
umol/l
0.67
70
578
11
34
3.60
2.86
1.8
2.3
1.22
1.46
g/l
0.61
11
27
46
311
2.19
2.80
8.4
5.5
1.21
1.21
mmol/l
0.11
40
278
29
164
2.23
2.74
3.4
3.1
397.74
4265.78
umol/l
0.78
23
132
12
42
3.19
2.70
3.3
7.2
93.48
92.83
%
0.16
12
42
70
587
3.11
2.63
33.8
21.0
3.99
4.02
mmol/l
0.38
70
566
70
585
3.16
2.62
32.8
21.1
139.06
139.58
mmol/l
0.80
70
565
9
27
3.63
2.48
2.7
1.8
—
—
—
0
0
39
256
2.06
2.47
2.6
2.5
75.19
75.16
nmol/l
0.00
34
218
11
39
3.12
2.46
1.9
4.4
52.80
48.21
ml/min/173m2
—
5
14
8
22
3.93
2.44
1.0
1.3
—
—
—
0
0
65
524
2.54
2.35
27.8
18.1
67.25
70.42
ml/min/173m2
0.59
59
439
63
502
2.40
2.32
4.7
4.5
1.20
1.22
mmol/l
0.13
57
434
11
41
2.96
2.32
3.1
4.7
25.16
25.03
mmol/l
0.03
11
41
21
111
2.23
2.29
4.2
3.1
1.50
2.23
e6/l
0.27
14
70
65
527
2.50
2.27
6.4
7.4
40.29
41.81
mmol/mol
0.58
59
483
6
14
4.55
2.19
1.3
1.4
—
—
—
0
0
65
530
2.45
2.19
5.1
5.0
3.99
4.30
mmol/l
1.91
59
467
60
474
2.20
2.18
11.3
7.2
81.93
77.55
u/l
0.58
55
443
14
64
2.45
2.09
3.0
6.7
115.36
122.44
g/l
0.59
14
64
45
327
1.91
2.00
3.5
2.9
49.39
53.52
u/l
0.19
38
301
66
549
2.42
1.99
6.0
5.7
2.20
2.44
mmol/l
1.64
60
478
38
262
1.89
1.98
5.2
3.4
—
—
—
0
0
68
583
2.42
1.97
17.0
11.3
23.14
23.31
u/l
0.04
63
558
31
200
1.92
1.97
3.3
3.8
4.75
11.02
mg/mmol
1.06
24
125
18
97
2.12
1.86
3.4
4.9
103.06
104.19
mmol/l
0.37
18
97
13
61
2.36
1.84
2.5
2.1
308.62
213.66
ng/l
0.30
13
52
34
231
1.84
1.82
3.1
3.5
2.37
2.34
mmol/l
0.42
29
196
30
196
1.87
1.81
5.9
3.3
0.14
0.43
e6/l
1.60
25
150
23
139
1.93
1.74
4.4
3.8
606.67
183.63
ng/l
0.34
18
121
63
526
2.09
1.70
5.1
5.0
1.35
1.43
mmol/l
0.63
57
459
61
505
2.00
1.66
4.5
4.9
1.94
2.05
mu/l
0.32
55
434
5
14
3.74
1.64
2.0
1.3
—
—
—
0
0
45
341
1.77
1.62
9.6
6.1
1.21
1.21
mmol/l
0.02
40
282
50
393
1.78
1.56
3.1
4.0
15.25
15.29
pmol/l
0.04
45
340
17
98
1.94
1.46
11.2
5.5
1.11
1.04
mmol/l
0.35
17
83
5
18
2.90
1.30
2.6
2.0
—
—
—
0
0
6
25
2.51
1.27
1.0
1.1
—
—
—
0
0
6
25
2.51
1.27
4.5
2.2
—
—
—
0
0
33
250
1.56
1.06
3.8
3.2
2708.21
1538.38
ng/l
0.93
28
208
7
34
2.16
1.06
1.4
2.6
1.33
1.11
%
—
7
34
8
43
1.96
0.91
1.8
1.2
—
—
—
0
0
0
26
0.00
0.80
0.0
2.1
—
4.44
—
0
21
40
333
1.42
0.75
24.5
16.6
1.19
1.29
inr
—
9
102
27
211
1.43
0.71
2.4
2.3
59.00
60.76
u/l
0.09
22
195
11
70
1.67
0.69
8.7
9.6
—
—
—
0
0
15
105
1.53
0.66
4.0
2.7
2.27
2.25
g/l
0.05
15
92
15
105
1.53
0.66
4.2
2.7
18.72
22.17
%
0.68
15
89
23
178
1.42
0.63
4.2
3.0
34.39
35.96
u/l
0.12
23
170
6
38
1.63
0.56
4.8
2.4
—
—
—
0
0
59
543
1.37
0.49
5.9
5.5
6.08
6.15
mmol/l
0.15
53
475
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
5
36
1.42
0.39
1.4
3.3
25.68
24.43
mmol/l
—
5
36
5
79
0.61
0.37
1.2
1.3
—
3.14
—
0
30
7
56
1.27
0.30
1.1
1.4
—
—
—
0
0
7
56
1.27
0.30
1.1
1.3
—
—
—
0
0
32
287
1.20
0.27
6.0
4.7
33.36
40.14
ng/l
0.36
25
234
5
40
1.27
0.23
1.4
4.0
52.70
49.42
%
—
5
40
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
8
71
1.14
0.17
4.3
4.0
—
—
—
0
0
21
190
1.14
0.15
3.6
4.5
25.37
21.60
%
0.52
15
90
13
114
1.17
0.13
2.5
1.9
29.63
30.04
s
0.12
13
106
5
45
1.12
0.10
3.0
2.2
13.74
12.90
nmol/l
—
5
38
25
249
1.01
0.00
4.5
5.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.8
—
61.00
—
0
5
0
7
0.00
-0.00
0.0
3.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.0
—
17.07
—
0
9
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_SKIN_EYELID – Carcinoma in situ of skin of eyelid, including canthus
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).